Insider · CIK 0002035283
Ting Xiao
Files at ZBIO (Zenas BioPharma, Inc.). First filing Apr 28, 2025, latest Apr 28, 2025.
In brief
Ting Xiao files SEC Form 4 as director at ZBIO (Zenas BioPharma, Inc.). Since Apr 28, 2025, Ting Xiao has reported 1 open-market buy worth $78k and 0 open-market sells worth $0, the latest filed on Apr 28, 2025.
A track record needs three past buys with six months of prices behind them; Ting Xiao has 0, so none is measured yet.
The newest scored trade: bought $78k of ZBIO on Feb 7, 2025, filed Apr 28, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZBIO: Zenas BioPharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ZBIObuy Zenas BioPharma, Inc. | $78k 10,000 shares | - | +20% from low-70% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | ZBIO Zenas BioPharma, Inc. | POpen-market purchase Common Stock | +10,000 | $7.76 | $78k | 10,000 | Apr 28, 2025 |
Questions about Ting Xiao
Answered from the filings on this page, as of the latest one.
Is Ting Xiao buying or selling?
Not in the last 12 months. Ting Xiao's latest open-market trade on SEC Form 4 was bought $78k of ZBIO on Feb 7, 2025.
How did Ting Xiao's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ting Xiao has 0.
Where does Ting Xiao file Form 4?
Ting Xiao has filed Form 4 at ZBIO (Zenas BioPharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.